Póster
Nº 023
Póster |
|
PRADA PUENTES CARLOS, RUIZ DE VALBUENA BUENO CARMEN,ALVAREZ ALVAREZ CARLOS,ESTEVEZ ESTEVEZ EMILIO*, ARNAL MONREAL FRANCISCO, VAZQUEZ MARTUL EDUARDO
|
|
1.- Davies SE, Portmann BC, O´Grady JG, Aldis PM, Chaggar K, Graemem JMA, Williams R. hepatic histological findings after transplantation chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150-157.
2.- Dickson RC, Caldwell SH, Ishitani MB, lau JYN, Driscoll CJ, Stevenson WC, McCullough CS, Pruett TL. Clinical and histological patterns of early graft failure due to recurrent hepatitis in four patients after liver transplantation. Transplantation 1996; 61: 701-705.
3.- Huang EJ, Wright TL, lake JR, Combs C, Ferrell LD. Hepatitis b and C coinfections and persistent hepatitis b infections: clinical outcome and liver pathology after trasplantation. Hepatology 1996; 23: 396-404.
4.- Lam PWY, Wachs ME, Somberg KA, Vincenti F, Lake JR, ferrell LD. Fibrosing cholestatic hepatitis in renal trasplant recipients. Transplantation 1996; 61: 378-381.
5.- McIvor C, Morton J, Bryant A, Cooksley WG, Durrant S, Walker N. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Annals of Internal Medicine 1994; 121: 274-275.
6.- Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B. Lancet 1993; 342: 1175.
7.- Lim HL, Lau GKK, davis GL, Dolson DJ, Lau JYN. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248-251.
8.- Lau JYN, Bain VG, Davies SE, O´Grady JG, Alberti A, Graeme JMA, Williams R. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956-962.
9.- Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987; 84: 6909:6913.
10.- Roingeard P, Romet-Lemonne JL, Leturcq D, Goudeau A, Essex M. hepatitis B virus core antigen (HBcAg) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopatic effect. Virology 1990;179: 113-120.
11.- Jamal H, Regenstein F, Farr G, Perrillo R. Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy. Am J Gastroenterology 1996; 91: 1027-1030.
12.- Lucey MR, Graham DM, Martin P, DiBiscelglie A, Rosenthal S, Waggoner JG, merion RM, y cols. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992; 33: 1390-1396.
13.- Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H y cols. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842-1847.
|
|
